Table of Contents 1 Intravenous Solutions (Colloids) Market Overview 1.1 Product Overview and Scope of Intravenous Solutions (Colloids) 1.2 Intravenous Solutions (Colloids) Segment by Type 1.2.1 Global Intravenous Solutions (Colloids) Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Peripheral Parenteral Nutrition 1.2.3 Total Parenteral Nutrition 1.3 Intravenous Solutions (Colloids) Segment by Application 1.3.1 Intravenous Solutions (Colloids) Sales Comparison by Application: 2020 VS 2026 1.3.2 Hospital & Clinics 1.3.3 Ambulatory 1.3.4 Home Care 1.4 Global Intravenous Solutions (Colloids) Market Size Estimates and Forecasts 1.4.1 Global Intravenous Solutions (Colloids) Revenue 2015-2026 1.4.2 Global Intravenous Solutions (Colloids) Sales 2015-2026 1.4.3 Intravenous Solutions (Colloids) Market Size by Region: 2020 Versus 2026 2 Global Intravenous Solutions (Colloids) Market Competition by Manufacturers 2.1 Global Intravenous Solutions (Colloids) Sales Market Share by Manufacturers (2015-2020) 2.2 Global Intravenous Solutions (Colloids) Revenue Share by Manufacturers (2015-2020) 2.3 Global Intravenous Solutions (Colloids) Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Intravenous Solutions (Colloids) Manufacturing Sites, Area Served, Product Type 2.5 Intravenous Solutions (Colloids) Market Competitive Situation and Trends 2.5.1 Intravenous Solutions (Colloids) Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Intravenous Solutions (Colloids) Players (Opinion Leaders) 3 Intravenous Solutions (Colloids) Retrospective Market Scenario by Region 3.1 Global Intravenous Solutions (Colloids) Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Intravenous Solutions (Colloids) Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Intravenous Solutions (Colloids) Market Facts & Figures by Country 3.3.1 North America Intravenous Solutions (Colloids) Sales by Country 3.3.2 North America Intravenous Solutions (Colloids) Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Intravenous Solutions (Colloids) Market Facts & Figures by Country 3.4.1 Europe Intravenous Solutions (Colloids) Sales by Country 3.4.2 Europe Intravenous Solutions (Colloids) Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Intravenous Solutions (Colloids) Market Facts & Figures by Region 3.5.1 Asia Pacific Intravenous Solutions (Colloids) Sales by Region 3.5.2 Asia Pacific Intravenous Solutions (Colloids) Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Intravenous Solutions (Colloids) Market Facts & Figures by Country 3.6.1 Latin America Intravenous Solutions (Colloids) Sales by Country 3.6.2 Latin America Intravenous Solutions (Colloids) Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Intravenous Solutions (Colloids) Market Facts & Figures by Country 3.7.1 Middle East and Africa Intravenous Solutions (Colloids) Sales by Country 3.7.2 Middle East and Africa Intravenous Solutions (Colloids) Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Intravenous Solutions (Colloids) Historic Market Analysis by Type 4.1 Global Intravenous Solutions (Colloids) Sales Market Share by Type (2015-2020) 4.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Type (2015-2020) 4.3 Global Intravenous Solutions (Colloids) Price Market Share by Type (2015-2020) 4.4 Global Intravenous Solutions (Colloids) Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Intravenous Solutions (Colloids) Historic Market Analysis by Application 5.1 Global Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020) 5.2 Global Intravenous Solutions (Colloids) Revenue Market Share by Application (2015-2020) 5.3 Global Intravenous Solutions (Colloids) Price by Application (2015-2020) 6 Company Profiles and Key Figures in Intravenous Solutions (Colloids) Business 6.1 ICU Medical Inc. 6.1.1 Corporation Information 6.1.2 ICU Medical Inc. Description, Business Overview and Total Revenue 6.1.3 ICU Medical Inc. Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2015-2020) 6.1.4 ICU Medical Inc. Products Offered 6.1.5 ICU Medical Inc. Recent Development 6.2 B. Braun Melsungen AG 6.2.1 B. Braun Melsungen AG Intravenous Solutions (Colloids) Production Sites and Area Served 6.2.2 B. Braun Melsungen AG Description, Business Overview and Total Revenue 6.2.3 B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2015-2020) 6.2.4 B. Braun Melsungen AG Products Offered 6.2.5 B. Braun Melsungen AG Recent Development 6.3 Fresenius Kabi AG 6.3.1 Fresenius Kabi AG Intravenous Solutions (Colloids) Production Sites and Area Served 6.3.2 Fresenius Kabi AG Description, Business Overview and Total Revenue 6.3.3 Fresenius Kabi AG Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Fresenius Kabi AG Products Offered 6.3.5 Fresenius Kabi AG Recent Development 6.4 Baxter 6.4.1 Baxter Intravenous Solutions (Colloids) Production Sites and Area Served 6.4.2 Baxter Description, Business Overview and Total Revenue 6.4.3 Baxter Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Baxter Products Offered 6.4.5 Baxter Recent Development 6.5 Amanta Healthcare 6.5.1 Amanta Healthcare Intravenous Solutions (Colloids) Production Sites and Area Served 6.5.2 Amanta Healthcare Description, Business Overview and Total Revenue 6.5.3 Amanta Healthcare Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Amanta Healthcare Products Offered 6.5.5 Amanta Healthcare Recent Development 6.6 Terumo Medical Corporation 6.6.1 Terumo Medical Corporation Intravenous Solutions (Colloids) Production Sites and Area Served 6.6.2 Terumo Medical Corporation Description, Business Overview and Total Revenue 6.6.3 Terumo Medical Corporation Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Terumo Medical Corporation Products Offered 6.6.5 Terumo Medical Corporation Recent Development 6.7 Grifols S.A. 6.6.1 Grifols S.A. Intravenous Solutions (Colloids) Production Sites and Area Served 6.6.2 Grifols S.A. Description, Business Overview and Total Revenue 6.6.3 Grifols S.A. Intravenous Solutions (Colloids) Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Grifols S.A. Products Offered 6.7.5 Grifols S.A. Recent Development 7 Intravenous Solutions (Colloids) Manufacturing Cost Analysis 7.1 Intravenous Solutions (Colloids) Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Intravenous Solutions (Colloids) 7.4 Intravenous Solutions (Colloids) Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Intravenous Solutions (Colloids) Distributors List 8.3 Intravenous Solutions (Colloids) Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Intravenous Solutions (Colloids) Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Intravenous Solutions (Colloids) by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Intravenous Solutions (Colloids) by Type (2021-2026) 10.2 Intravenous Solutions (Colloids) Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Intravenous Solutions (Colloids) by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Intravenous Solutions (Colloids) by Application (2021-2026) 10.3 Intravenous Solutions (Colloids) Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Intravenous Solutions (Colloids) by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Intravenous Solutions (Colloids) by Region (2021-2026) 10.4 North America Intravenous Solutions (Colloids) Estimates and Projections (2021-2026) 10.5 Europe Intravenous Solutions (Colloids) Estimates and Projections (2021-2026) 10.6 Asia Pacific Intravenous Solutions (Colloids) Estimates and Projections (2021-2026) 10.7 Latin America Intravenous Solutions (Colloids) Estimates and Projections (2021-2026) 10.8 Middle East and Africa Intravenous Solutions (Colloids) Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Intravenous Solutions (Colloids) Sales (K Units) Growth Rate Comparison by Type (2015-2026) Table 2. Global Intravenous Solutions (Colloids) Sales (K Units) Comparison by Application: 2020 VS 2026 Table 3. Global Intravenous Solutions (Colloids) Market Size by Type (K Units) (US$ Million) (2020 VS 2026) Table 4. Global Key Intravenous Solutions (Colloids) Manufacturers Covered in This Study Table 5. Global Intravenous Solutions (Colloids) Sales (K Units) by Manufacturers (2015-2020) Table 6. Global Intravenous Solutions (Colloids) Sales Share by Manufacturers (2015-2020) Table 7. Global Intravenous Solutions (Colloids) Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Intravenous Solutions (Colloids) Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Intravenous Solutions (Colloids) Average Price (USD/Unit) of Key Manufacturers (2015-2020) Table 10. Manufacturers Intravenous Solutions (Colloids) Sales Sites and Area Served Table 11. Manufacturers Intravenous Solutions (Colloids) Product Types Table 12. Global Intravenous Solutions (Colloids) Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Intravenous Solutions (Colloids) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Solutions (Colloids) as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Intravenous Solutions (Colloids) Players Table 16. Global Intravenous Solutions (Colloids) Sales (K Units) by Region (2015-2020) Table 17. Global Intravenous Solutions (Colloids) Sales Market Share by Region (2015-2020) Table 18. Global Intravenous Solutions (Colloids) Revenue (Million US$) by Region (2015-2020) Table 19. Global Intravenous Solutions (Colloids) Revenue Market Share by Region (2015-2020) Table 20. North America Intravenous Solutions (Colloids) Sales by Country (2015-2020) (K Units) Table 21. North America Intravenous Solutions (Colloids) Sales Market Share by Country (2015-2020) Table 22. North America Intravenous Solutions (Colloids) Revenue by Country (2015-2020) (US$ Million) Table 23. North America Intravenous Solutions (Colloids) Revenue Market Share by Country (2015-2020) Table 24. Europe Intravenous Solutions (Colloids) Sales by Country (2015-2020) (K Units) Table 25. Europe Intravenous Solutions (Colloids) Sales Market Share by Country (2015-2020) Table 26. Europe Intravenous Solutions (Colloids) Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Intravenous Solutions (Colloids) Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Intravenous Solutions (Colloids) Sales by Region (2015-2020) (K Units) Table 29. Asia Pacific Intravenous Solutions (Colloids) Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Intravenous Solutions (Colloids) Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Intravenous Solutions (Colloids) Revenue Market Share by Region (2015-2020) Table 32. Latin America Intravenous Solutions (Colloids) Sales by Country (2015-2020) (K Units) Table 33. Latin America Intravenous Solutions (Colloids) Sales Market Share by Country (2015-2020) Table 34. Latin America Intravenous Solutions (Colloids) Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Intravenous Solutions (Colloids) Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Intravenous Solutions (Colloids) Sales by Country (2015-2020) (K Units) Table 37. Middle East and Africa Intravenous Solutions (Colloids) Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Intravenous Solutions (Colloids) Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Intravenous Solutions (Colloids) Revenue Market Share by Country (2015-2020) Table 40. Global Intravenous Solutions (Colloids) Sales (K Units) by Type (2015-2020) Table 41. Global Intravenous Solutions (Colloids) Sales Share by Type (2015-2020) Table 42. Global Intravenous Solutions (Colloids) Revenue (Million US$) by Type (2015-2020) Table 43. Global Intravenous Solutions (Colloids) Revenue Share by Type (2015-2020) Table 44. Global Intravenous Solutions (Colloids) Price (USD/Unit) by Type (2015-2020) Table 45. Global Intravenous Solutions (Colloids) Sales (K Units) by Application (2015-2020) Table 46. Global Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020) Table 47. Global Intravenous Solutions (Colloids) Sales Growth Rate by Application (2015-2020) Table 48. ICU Medical Inc. Intravenous Solutions (Colloids) Corporation Information Table 49. ICU Medical Inc. Description and Business Overview Table 50. ICU Medical Inc. Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 51. ICU Medical Inc. Main Product Table 52. ICU Medical Inc. Recent Development Table 53. B. Braun Melsungen AG Intravenous Solutions (Colloids) Corporation Information Table 54. B. Braun Melsungen AG Corporation Information Table 55. B. Braun Melsungen AG Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 56. B. Braun Melsungen AG Main Product Table 57. B. Braun Melsungen AG Recent Development Table 58. Fresenius Kabi AG Intravenous Solutions (Colloids) Corporation Information Table 59. Fresenius Kabi AG Corporation Information Table 60. Fresenius Kabi AG Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 61. Fresenius Kabi AG Main Product Table 62. Fresenius Kabi AG Recent Development Table 63. Baxter Intravenous Solutions (Colloids) Corporation Information Table 64. Baxter Corporation Information Table 65. Baxter Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 66. Baxter Main Product Table 67. Baxter Recent Development Table 68. Amanta Healthcare Intravenous Solutions (Colloids) Corporation Information Table 69. Amanta Healthcare Corporation Information Table 70. Amanta Healthcare Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 71. Amanta Healthcare Main Product Table 72. Amanta Healthcare Recent Development Table 73. Terumo Medical Corporation Intravenous Solutions (Colloids) Corporation Information Table 74. Terumo Medical Corporation Corporation Information Table 75. Terumo Medical Corporation Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 76. Terumo Medical Corporation Main Product Table 77. Terumo Medical Corporation Recent Development Table 78. Grifols S.A. Intravenous Solutions (Colloids) Corporation Information Table 79. Grifols S.A. Corporation Information Table 80. Grifols S.A. Intravenous Solutions (Colloids) Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020) Table 81. Grifols S.A. Main Product Table 82. Grifols S.A. Recent Development Table 83. Sales Base and Market Concentration Rate of Raw Material Table 84. Key Suppliers of Raw Materials Table 85. Intravenous Solutions (Colloids) Distributors List Table 86. Intravenous Solutions (Colloids) Customers List Table 87. Market Key Trends Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 89. Key Challenges Table 90. Global Intravenous Solutions (Colloids) Sales (K Units) Forecast by Type (2021-2026) Table 91. Global Intravenous Solutions (Colloids) Sales Market Share Forecast by Type (2021-2026) Table 92. Global Intravenous Solutions (Colloids) Revenue (Million US$) Forecast by Type (2021-2026) Table 93. Global Intravenous Solutions (Colloids) Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 94. Global Intravenous Solutions (Colloids) Sales (K Units) Forecast by Application (2021-2026) Table 95. Global Intravenous Solutions (Colloids) Revenue (Million US$) Forecast by Application (2021-2026) Table 96. Global Intravenous Solutions (Colloids) Sales (K Units) Forecast by Region (2021-2026) Table 97. Global Intravenous Solutions (Colloids) Sales Market Share Forecast by Region (2021-2026) Table 98. Global Intravenous Solutions (Colloids) Revenue Forecast by Region (2021-2026) (US$ Million) Table 99. Global Intravenous Solutions (Colloids) Revenue Market Share Forecast by Region (2021-2026) Table 100. Research Programs/Design for This Report Table 101. Key Data Information from Secondary Sources Table 102. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Intravenous Solutions (Colloids) Figure 2. Global Intravenous Solutions (Colloids) Sales Market Share by Type: 2020 VS 2026 Figure 3. Peripheral Parenteral Nutrition Product Picture Figure 4. Total Parenteral Nutrition Product Picture Figure 5. Global Intravenous Solutions (Colloids) Consumption Market Share by Application: 2020 VS 2026 Figure 6. Hospital & Clinics Figure 7. Ambulatory Figure 8. Home Care Figure 9. Global Intravenous Solutions (Colloids) Market Size 2015-2026 (US$ Million) Figure 10. Global Intravenous Solutions (Colloids) Sales Capacity (K Units) (2015-2026) Figure 11. Global Intravenous Solutions (Colloids) Market Size Market Share by Region: 2020 Versus 2026 Figure 12. Intravenous Solutions (Colloids) Sales Share by Manufacturers in 2020 Figure 13. Global Intravenous Solutions (Colloids) Revenue Share by Manufacturers in 2019 Figure 14. The Global 5 and 10 Largest Players: Market Share by Intravenous Solutions (Colloids) Revenue in 2019 Figure 15. Intravenous Solutions (Colloids) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 16. Global Intravenous Solutions (Colloids) Sales Market Share by Region (2015-2020) Figure 17. Global Intravenous Solutions (Colloids) Sales Market Share by Region in 2019 Figure 18. Global Intravenous Solutions (Colloids) Revenue Market Share by Region (2015-2020) Figure 19. Global Intravenous Solutions (Colloids) Revenue Market Share by Region in 2019 Figure 20. North America Intravenous Solutions (Colloids) Sales Market Share by Country in 2019 Figure 21. North America Intravenous Solutions (Colloids) Revenue Market Share by Country in 2019 Figure 22. U.S. Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 23. U.S. Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 24. Canada Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 25. Canada Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Europe Intravenous Solutions (Colloids) Sales Market Share by Country in 2019 Figure 27. Europe Intravenous Solutions (Colloids) Revenue Market Share by Country in 2019 Figure 28. Germany Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 29. Germany Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 30. France Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 31. France Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. U.K. Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 33. U.K. Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. Italy Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 35. Italy Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Russia Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 37. Russia Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Asia Pacific Intravenous Solutions (Colloids) Sales Market Share by Region in 2019 Figure 39. Asia Pacific Intravenous Solutions (Colloids) Revenue Market Share by Region in 2019 Figure 40. China Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 41. China Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 42. Japan Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 43. Japan Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. South Korea Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 45. South Korea Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. India Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 47. India Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. Australia Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 49. Australia Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Taiwan Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 51. Taiwan Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Indonesia Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 53. Indonesia Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Thailand Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 55. Thailand Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Malaysia Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 57. Malaysia Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Philippines Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 59. Philippines Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Vietnam Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 61. Vietnam Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Latin America Intravenous Solutions (Colloids) Sales Market Share by Country in 2019 Figure 63. Latin America Intravenous Solutions (Colloids) Revenue Market Share by Country in 2019 Figure 64. Mexico Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 65. Mexico Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 66. Brazil Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 67. Brazil Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Argentina Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 69. Argentina Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Middle East and Africa Intravenous Solutions (Colloids) Sales Market Share by Country in 2019 Figure 71. Middle East and Africa Intravenous Solutions (Colloids) Revenue Market Share by Country in 2019 Figure 72. Turkey Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 73. Turkey Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 74. Saudi Arabia Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 75. Saudi Arabia Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. U.A.E Intravenous Solutions (Colloids) Sales Growth Rate (2015-2020) (K Units) Figure 77. U.A.E Intravenous Solutions (Colloids) Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. Sales Market Share of Intravenous Solutions (Colloids) by Type (2015-2020) Figure 79. Sales Market Share of Intravenous Solutions (Colloids) by Type in 2019 Figure 80. Revenue Share of Intravenous Solutions (Colloids) by Type (2015-2020) Figure 81. Revenue Market Share of Intravenous Solutions (Colloids) by Type in 2019 Figure 82. Global Intravenous Solutions (Colloids) Sales Growth by Type (2015-2020) (K Units) Figure 83. Global Intravenous Solutions (Colloids) Sales Market Share by Application (2015-2020) Figure 84. Global Intravenous Solutions (Colloids) Sales Market Share by Application in 2019 Figure 85. Global Revenue Share of Intravenous Solutions (Colloids) by Application (2015-2020) Figure 86. Global Revenue Share of Intravenous Solutions (Colloids) by Application in 2020 Figure 87. ICU Medical Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 88. B. Braun Melsungen AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 89. Fresenius Kabi AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Baxter Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Amanta Healthcare Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Terumo Medical Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Grifols S.A. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Price Trend of Key Raw Materials Figure 95. Manufacturing Cost Structure of Intravenous Solutions (Colloids) Figure 96. Manufacturing Process Analysis of Intravenous Solutions (Colloids) Figure 97. Intravenous Solutions (Colloids) Industrial Chain Analysis Figure 98. Channels of Distribution Figure 99. Distributors Profiles Figure 100. Porter's Five Forces Analysis Figure 101. North America Intravenous Solutions (Colloids) Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 102. North America Intravenous Solutions (Colloids) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 103. Europe Intravenous Solutions (Colloids) Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 104. Europe Intravenous Solutions (Colloids) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 105. Latin America Intravenous Solutions (Colloids) Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 106. Latin America Intravenous Solutions (Colloids) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 107. Middle East and Africa Intravenous Solutions (Colloids) Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 108. Middle East and Africa Intravenous Solutions (Colloids) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 109. Asia Pacific Intravenous Solutions (Colloids) Sales (K Units) and Growth Rate Forecast (2021-2026) Figure 110. Asia Pacific Intravenous Solutions (Colloids) Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 111. Bottom-up and Top-down Approaches for This Report Figure 112. Data Triangulation Figure 113. Key Executives Interviewed

ICU Medical Inc. B. Braun Melsungen AG Fresenius Kabi AG Baxter Amanta Healthcare Terumo Medical Corporation Grifols S.A.